Abstract
The disposition and metabolism of narcotic drugs have been an extremely active area of research during the past few decades. Much effort has been extended in this area due to two factors: (1) a search for the mechanism of action of analgesic drugs and/or the mechanism of tolerance and physical dependence and (2) the need for basic data concerning the disposition and metabolism of a new drug prior to release for clinical experimentation and subsequent filing of a new drug application.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E. L. Way and T. K. Adler, Pharmacol. Rev. 12, 383–445 (1960).
E. L. Way and T. K. Adler, “The Biological Disposition of Morphine and its Surrogates,” World Health Organization, Geneva, pp. 1–114 (1962).
E. L. Way, in The Addictive States (A. Wikler, ed.), Vol. 46, pp. 13–31, Williams & Wilkins, Baltimore (1968).
E. Nelson, J. Pharm. Sci., 50, 181–192 (1961).
B. B. Brodie and C. A. M. Hogben, J. Pharm. Pharmacol. 9, 345–380 (1957).
J. G. Wagner, J. Pharm. Sci. 56, 489–494 (1967).
J. H. Fincher, J. Pharm. Sci. 57, 1825–1835 (1968).
A. Goldstein, L. Arnow, and S. M. Kaiman, “Principles of Drug Action,” Hoeber Medical Division, Harper & Row, New York (1968).
C. G. Farmilo, P. M. Oestreicher, and L. Levi, Bull. Narcotics 6, 7–19 (1954).
L. B. Mellett, unpublished observations.
S. J. Kety, in “Handbook of Physiology” (J. Field, H. W. Magoon, and L. E. Hall, eds.), Vol. III, “Neurophysiology,” Chapter 71, American Physiological Society, Washington, D.C. (1960).
B. B. Brodie, H. Kurr, and L. Shanker, J. Pharmacol. Exp. Ther. 130, 20–25 (1960).
L. J. Shanker, Ann. Rev. Pharmacol. 1, 29–44 (1961).
D. P. Rall and C. G. Zabrod, Ann. Rev. Pharmacol. 2, 109–128 (1962).
L. J. Roth and L. F. Barlow, Science 134, 22–31 (1961).
W. Feldberg, “A Pharmacological Approach to the Brain, from its Inner and Outer Surface,” Williams & Wilkins, Baltimore (1963).
S. J. Mulé, Arch Int. Pharmacodyn. 173, 201–212 (1968).
R. T. Williams, “Detoxication Mechanisms,” Wiley, New York (1959).
J. M. Fujimoto and E. L. Way, Fed. Proc. 13, 58 (1954).
R. A. Seibert, C. W. Williams, and R. A. Huggins, Science 120, 222 (1954).
L. A. Woods, J. Pharmacol. Exp. Ther. 112, 158–175 (1954).
J. L. Strominger, H. M. Kalckar, J. Axelrod, and E. S. Maxwell, J. Amer. Chem. Soc. 76, 6411–6412 (1954).
A. E. Takemori, J. Pharmacol. Exp. Ther. 130, 370–374 (1960).
T. K. Adler, in “Current Trends in Heterocyclic Chemistry” (A. Albert, G. M. Bodger, and C. W. Shappee, eds.), Butterworths, London, pp. 151–157 (1958).
L. A. Woods and H. E. Muehlenbeck, J. Pharmacol. Exp. Ther. 120, 52–57 (1957).
G. J. Mannering and L. S. Schanker, J. Pharmacol. Exp. Ther. 124, 296–304 (1958).
C. C. Hug, Jr., and L. B. Mellett, J. Pharmacol. Exp. Ther. 149, 446–453 (1965).
H. Fisher and J. P. Long, J. Pharmacol. Exp. Ther. 107, 241–246 (1953).
N. P. Plotnikoff, E. L. Way, and H. W. Elliott, J. Pharmacol. Exp. Ther. 117, 414–419 (1956).
S. J. Mulé and C. W. Gorodetzky, J. Pharmacol. Exp. Ther. 154, 632–645 (1966).
S. J. Mulé, T. H. Clements, and C. W. Gorodetzky, J. Pharmacol. Exp. Ther. 160, 387–396 (1968).
J. M. Fujimoto and V. B. Haarstad, J. Pharmacol. Exp. Ther. 165, 45–51 (1969).
J. M. Fujimoto, W. W. Watrous, and V. B. Haarstad, Proc. Soc. Exp. Biol. Med. 130, 546–549 (1969).
J. R. Gillette, in “Progress in Drug Research” (E. Tucker, ed.), Vol. 6, pp. 11–51, Birkhauser Verlag, Basel (1963).
A. H. Beckett, J. Pharm. Pharmacol. 8, 848–859 (1956).
J. Axelrod, Science 124, 263–264 (1956).
D. H. Clouet, “International Review of Neurobiology,” Vol. II, pp. 99–128, Academic Press, New York (1968).
T. K. Adler, Proc. Soc. Exp. Biol. Med. 73, 401–404 (1950).
T. K. Adler, J. Pharmacol. Exp. Ther. 103, 337 (1951).
T. K. Adler, J. Pharmacol. Exp. Ther. 106, 371 (1952).
G. J. Mannering, A. C. Dixon, E. M. Baker, and T. Asami, J. Pharmacol. Exp. Ther. 111, 142–146 (1954).
T. K. Adler, J. Pharmacol. Exp. Ther. 140, 155–161 (1963).
J. W. Miller and H. W. Elliott, J. Pharmacol. Exp. Ther. 113, 283–291 (1955).
S. Y. Yeh and L. A. Woods, J. Pharmacol. Exp. Ther. 166, 86–95 (1969).
P. Paerregaard, Acta Pharmacol. Toxicol. 14, 394–399 (1958).
L. A. Woods, H. E. Muehlenbeck, and L. B. Mellett, J. Pharmacol. Exp. Ther. 117, 117–125 (1956).
T. K. Adler, J. M. Fujimoto, E. L. Way, and E. M. Baker, J. Pharmacol. Exp. Ther. 114, 251 (1955).
A. E. Takemori and G. J. Mannering, J. Pharmacol. Exp. Ther. 123, 171–179 (1958).
E. L. Way, J. W. Kemp, J. M. Young, and D. R. Grassetti, J. Pharmacol. Exp. Ther. 129, 144–151 (1960).
E. L. Way, J. M. Young, and J. W. Kemp, Bull. Narcotics 17, 25–33 (1965).
J. J. Burns, B. L. Berger, P. A. Lief, A. Wollack, E. M. Papper, and B. B. Brodie, J. Pharmacol. Exp. Ther. 114, 289–295 (1955).
F. Bernheim and M. Bernheim, J. Pharmacol. Exp. Ther. 85, 74–77 (1945).
E. L. Way, R. Swanson, and A. Gimble, J. Pharmacol. Exp. Ther. 91, 178–184 (1947).
W. P. Baker and L. A. Woods, J. Pharmacol. Exp. Ther. 120, 371–374 (1957).
C. C. Hug, L. B. Mellett, and E. J. Cafruny, J. Pharmacol. Exp. Ther. 150, 259–269 (1965).
C. H. March and H. W. Elliott, Proc. Soc. Exp. Biol. Med. 86, 494–497 (1954).
J. Cochin, J. Haggart, L. A. Woods, and M. H. Seevers, J. Pharmacol. Exp. Ther. 111, 74–83 (1954).
L. B. Mellett and L. A. Woods, J. Pharmacol. Exp. Ther. 116, 77–83 (1956).
L. A. Woods, J. Pharmacol. Exp. Ther. 120, 58–62 (1956).
S. J. Mulé and L. A. Woods, J. Pharmacol. Exp. Ther. 136, 232–241 (1962).
S. J. Mulé, L. A. Woods, and L. B. Mellett, J. Pharmacol. Exp. Ther. 136, 242–249 (1962).
S. J. Mulé, J. Pharmacol. Exp. Ther. 148, 393–398 (1965).
R. Siminoff and P. R. Saunders, J. Pharmacol. Exp. Ther. 124, 252–254 (1958).
T. K. Adler, H. W. Elliott, and R. George, J. Pharmacol. Exp. Ther. 120, 475–487 (1957).
J. C. Szerb and D. H. McCurdy, J. Pharmacol. Exp. Ther. 118, 446–450 (1956).
T. Johannesson, Acta Pharmacol. Toxicol. 19, 286–292 (1962).
T. Johannesson and K. Milthers, Acta Pharmacol. Toxicol. 19, 241–246 (1962).
T. Johannesson, Acta Pharmacol. Toxicol. 19, 23–35 (1962).
K. Milthers, Nature 195, 607 (1962).
K. Milthers, Acta Pharmacol. Toxicol. 19, 235–240 (1962).
T. Johannesson and J. Schou, Acta Pharmacol. Toxicol. 20, 165–173 (1963).
T. Johannesson and K. Milthers, Acta Pharmacol. Toxicol 20, 80–89 (1963).
T. Johannesson and L. A. Woods, Acta Pharmacol. Toxicol. 21, 381–396 (1964).
S. J. Mulé, C. M. Redman, and J. W. Flesher, J. Pharmacol. Exp. Ther. 157, 459–471 (1967).
H. I. Chernov and L. A. Woods, J. Pharmacol. Exp. Ther. 149, 146–155 (1965).
C. C. Hug, doctoral dissertation, University of Michigan, Ann Arbor, pp. 1–205 (1963).
C. F. Blane and H. Dobbs, Brit. J. Pharmacol. Chemother. 30, 166–172 (1967).
J. H. Samer and L. A. Woods, J. Pharmacol. Exp. Ther. 148, 176–184 (1965).
S. Y. Yeh and L. A. Woods, J. Pharmacol. Exp. Ther. 166, 86–95 (1969).
K. D. Wuepper, S. Y. Yeh and L. A. Woods, Proc. Soc. Exp. Biol Med. 124, 1146–1149 (1967).
C. C. Hug and L. A. Woods, J. Pharmacol. Exp. Ther. 142, 248–256 (1963).
K. D. Wuepper and L. A. Woods, Fed. Proc. 19, 272 (1960).
R. Ferrari, Pharmacologist 7, 148 (1965).
R. Ferrari and J. D. Connolly, Pharmacologist 8, 224 (1966).
J. Heng and L. A. Woods, Fed. Proc. 17, 376 (1968).
E. L. Way, A. I. Gimble, W. P. McKelway, H. Ross, Chen-Yo Sung, and H. Ellsworth, J. Pharmacol. Exp. Ther. 96, 477–484 (1949).
E. L. Way, Chen-Yo Sung, and W. P. McKelway, J. Pharmacol. Exp. Ther. 97, 222–228 (1949).
J. C. Richards, G. E. Boxer, and C. C. Smith, J. Pharmacol. Exp. Ther. 98, 380–391 (1950).
L. A. Woods, J. Cochin, E. G. Fornfeld, and M. H. Seevers, J. Pharmacol. Exp. Ther. 111, 64–73 (1954).
H. W. Elliott, F. N. H. Chang, I. A. Abdou, and H. H. Anderson, J. Pharmacol. Exp. Ther. 95, 494–501 (1949).
N. B. Eddy, H. Halbach, O. J. Brenden, Bull. W. H. O. 14, 353–402 (1956).
D. Van Praag and E. J. Simon, Proc. Soc. Exp. Biol. Med. 122, 6–11 (1966).
A. H. Beckett, A. F. Casy, and N. J. Harper, J. Pharm. Pharmacol. 8, 874–883 (1956).
A. L. Misra, S. J. Mulé, and L. A. Woods, J. Pharmacol. Exp. Ther. 132, 317–322 (1961).
A. L. Misra, H. I. Jacoby, and L. A. Woods, J. Pharmacol. Exp. Ther. 132, 311–316 (1961).
N. P. Plotnikoff, H. W. Elliott, and E. L. Way, J. Pharmacol. Exp. Ther. 104, 377–386 (1952).
L. A. Woods, L. B. Mellett, and K. J. Anderson, J. Pharmacol. Exp. Ther. 124, 1–8 (1958).
V. P. Dole and M. E. Nyswander, J. Amer. Med. Ass. 193, 647–650 (1965).
V. P. Dole and M. E. Nyswander, Brit. J. Addict. 63, 55–57 (1968).
A. H. Beckett, J. F. Taylor, A. F. Casy, and M. M. A. Hassan, J. Pharm. Pharmacol. 20, 754–762 (1968).
W. R. Martin, Pharm. Rev. 19, 464–521 (1967).
S. Archer and L. S. Harris, in “Progress in Drug Research” (E. J. Jucker, ed.), pp. 261–320, Birkhauser Verlag, Basel (1965).
R. A. Ferrari, Toxicol. Appl. Pharm. 12, 404–416 (1968).
A. S. Kates and J. Telford, J. Pharmacol. Exp. Ther. 143, 157–164 (1964).
J. Cochin, in “Enzymes in Mental Health” (G. J. Martin and B. Kisch, eds.), pp. 27–42, Lippincott, Philadelphia (1966).
M. H. Seevers and L. A. Woods, Amer. J. Med. 14, 546–557 (1953).
N. B. Eddy, H. Halbach, H. Isbell, and M. H. Seevers, Bull. W. H. O. 32, 721–733 (1965).
L. B. Mellett and L. A. Woods, Prog. Drug Res. 5, 157–267 (1963).
M. H. Seevers and G. A. Deneau, Arch Int. Pharmacodyn. 140, 514–520 (1962).
W. R. Martin, in “The Addictive States” (A. Wikler, ed.), Vol. 46, pp. 206–225, Williams & Wilkins, Baltimore (1968).
J. H. Jaffe and S. K. Sharpless, in “The Addictive States” (A. Wikler, ed.), Vol. 46, 226–246, Williams & Wilkins, Baltimore (1968).
J. Axelrod, in “The Addictive States” (A. Wikler, ed.), Vol. 46, 247–264, Williams & Wilkins, Baltimore, (1968).
A. Goldstein and D. B. Goldstein, in “The Addictive States” (A. Wikler, ed.), Vol. 46, 265–267, Williams & Wilkins, Baltimore (1968).
N. D. Eddy, in “Origin of Resistence to Toxic Agents” (M. G. Sevay, R. D. Reid, and O. E. Reynolds, eds.), pp. 223–243, Academic Press, New York (1955).
S. J. Mulé, in “Scientific Basis of Drug Dependence” (H. Steinberg, ed.), pp. 97–109, Churchill Ltd., London (1969).
L. A. Woods, Pharm. Rev. 84, 175–198 (1956).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Plenum Press, New York
About this chapter
Cite this chapter
Mulé, S.J. (1971). Physiological Disposition of Narcotic Agonists and Antagonists. In: Clouet, D.H. (eds) Narcotic Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1869-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1869-9_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1871-2
Online ISBN: 978-1-4684-1869-9
eBook Packages: Springer Book Archive